Point_NN Mutations_NNS in_IN Exon_NP I_NP of_IN the_DT Herpes_NP Simplex_NP Virus_NP Putative_NP Terminase_NP Subunit_NP ,_, UL15_NP ,_, Indicate_VBG that_IN the_DT Most_RBS Conserved_JJ Residues_NNS Are_VBP Essential_JJ for_IN Cleavage_NP and_CC Packaging_NP The_DT herpes_NN simplex_NN virus_NN UL15_NP and_CC UL28_NP genes_NNS are_VBP believed_VBN to_TO encode_VB two_CD subunits_NN of_IN the_DT terminase_NN involved_VBN in_IN cleavage_NN and_CC packaging_NN of_IN viral_JJ genomes_NNS ._SENT Analysis_NN of_IN the_DT UL15_NP protein_NN sequence_NN and_CC its_PP$ herpesvirus_NN homologues_NNS revealed_VBD the_DT presence_NN of_IN 20_CD conserved_VBN regions_NNS ._SENT Twelve_CD of_IN the_DT twenty_CD regions_NNS conserved_VBN among_IN herpesviruses_NNS are_VBP also_RB conserved_VBN in_IN terminases_NNS from_IN DNA_NN bacteriophage_NN ._SENT Point_NN mutations_NNS in_IN UL15_NP were_VBD designed_VBN in_IN four_CD conserved_VBN regions_NNS :_: L120N_NP (_( CR1_NP )_) ,_, Q205E_NP (_( CR2_NP )_) ,_, Q251E_NP (_( CR3_NP )_) ,_, G263A_NP (_( CR3_NP )_) ,_, and_CC Y285S_NP (_( CR4_NP )_) ._SENT Transfection_NN experiments_NNS indicated_VBD that_IN each_DT mutant_JJ gene_NN could_MD produce_VB stable_JJ UL15_JJ protein_NN at_IN wild-type_NN levels_NNS ;_: however_RB ,_, only_RB one_CD mutant_NN (_( Q251E_NP )_) was_VBD able_JJ to_TO complement_VB the_DT UL15-null_NP virus_NN ._SENT Each_DT mutation_NN was_VBD introduced_VBN into_IN the_DT viral_JJ genome_NN by_IN marker_NN transfer_NN ,_, and_CC all_DT mutants_NNS except_IN Q251E_NNS were_VBD unable_JJ to_TO form_VB plaques_NNS on_IN Vero_NP cells_NNS ._SENT Furthermore_RB ,_, failure_NN to_TO form_VB plaques_NNS on_IN Vero_NP cells_NNS correlated_VBN with_IN a_DT defect_NN in_IN cleavage_NN and_CC packaging_NN ._SENT Immunofluorescence_NN experiments_NNS indicated_VBD that_IN in_IN cells_NNS infected_VBN with_IN all_DT mutant_JJ viruses_NNS the_DT UL15_NP protein_NN could_MD be_VB detected_VBN and_CC was_VBD found_VBN to_TO localize_VB to_TO replication_NN compartments_NNS ._SENT Although_IN wild-type_NN and_CC mutant_JJ Q251E_NNS were_VBD able_JJ to_TO produce_VB A_DT ,_, B_NP ,_, and_CC C_NP capsids_NNS ,_, the_DT rest_NN of_IN the_DT mutants_NNS were_VBD only_RB able_JJ to_TO produce_VB B_NP capsids_NNS ,_, a_DT finding_VBG consistent_JJ with_IN their_PP$ defects_NNS in_IN cleavage_NN and_CC packaging_NN ._SENT In_IN addition_NN ,_, all_DT mutant_JJ UL15_NP proteins_NNS retained_VBD their_PP$ ability_NN to_TO interact_VB with_IN B_NP capsids_NNS ._SENT Therefore_RB ,_, amino_NN acid_NN residues_NNS 120_CD ,_, 205_CD ,_, 263_CD ,_, and_CC 285_CD are_VBP essential_JJ for_IN the_DT cleavage_NN and_CC packaging_NN process_NN rather_RB than_IN for_IN association_NN with_IN capsids_NNS or_CC localization_NN to_TO replication_NN compartments_NNS ._SENT Herpes_NN simplex_JJ virus_NN type_NN 1_CD (_( HSV-1_NP )_) DNA_NN cleavage_NN and_CC packaging_NN involves_VBZ at_IN least_JJS seven_CD essential_JJ gene_NN products_NNS :_: UL6_NP ,_, UL15_NP ,_, UL17_NP ,_, UL25_NP ,_, UL28_NP ,_, UL32_NP ,_, and_CC UL33_NP (_( reviewed_VBN in_IN references_NNS and_CC )_) ._SENT This_DT complex_JJ process_NN has_VBZ been_VBN compared_VBN to_TO the_DT better-studied_JJ bacteriophage_NN ,_, T4_NP and_CC lambda_NN ,_, in_IN which_WDT monomeric_JJ genomes_NNS are_VBP released_VBN from_IN the_DT concatemeric_JJ DNA_NN by_IN cleavage_NN and_CC subsequently_RB packaged_VBN into_IN preassembled_JJ capsids_NNS (_( reviewed_VBN in_IN references_NNS and_CC )_) ._SENT In_IN the_DT lambda_NN phage_NN system_NN ,_, gpA_NN and_CC gpNu_NN comprise_VBP a_DT two-subunit_JJ terminase_NN that_IN binds_NNS to_TO and_CC cleaves_VBZ concatemeric_JJ DNA_NN at_IN specific_JJ sequences_NNS ._SENT The_DT terminase_NN ,_, bound_VBN to_TO the_DT DNA_NN ,_, docks_NNS onto_IN the_DT prohead_NN at_IN a_DT unique_JJ portal_NN vertex_NN ._SENT Translocation_NN of_IN the_DT DNA_NN into_IN the_DT capsid_NN requires_VBZ ATP_NP hydrolysis_NN ._SENT The_DT DNA_NN is_VBZ cleaved_VBN at_IN specific_JJ sites_NNS ,_, and_CC the_DT terminase_NN ,_, with_IN the_DT remaining_VBG DNA_NN still_RB attached_VBN ,_, detaches_VBZ from_IN the_DT prohead_NN ._SENT Other_JJ phage_NN proteins_NNS such_JJ as_IN gpD_NNS and_CC gpW_NNS act_VBP to_TO stabilize_VB DNA_NN in_IN the_DT capsids_NNS ._SENT Recent_JJ experiments_NNS with_IN HSV_NP indicate_VBP that_IN the_DT herpesviruses_NNS may_MD encode_VB similar_JJ cleavage_NN and_CC packaging_NN machinery_NN ._SENT Newcomb_NP et_FW al._FW recently_RB reported_VBD that_IN the_DT HSV-1_NP UL6_NP protein_NN localizes_VBZ to_TO a_DT unique_JJ vertex_NN on_IN procapsids_NNS and_CC forms_VBZ a_DT 12-member_JJ ring_NN in_IN vitro_NN ;_: these_DT results_NNS suggest_VBP that_IN UL6_NP forms_VBZ a_DT unique_JJ portal_NN through_IN which_WDT the_DT viral_JJ DNA_NN enters_VBZ the_DT capsid_NN ._SENT After_IN packaging_NN ,_, UL25_NP may_MD play_VB a_DT role_NN in_IN stabilizing_VBG DNA_NN inside_IN the_DT capsid_NN ._SENT UL17_JJ and_CC UL32_NP may_MD act_VB to_TO transport_VB capsids_NNS to_TO replication_NN compartments_NNS (_( RCs_NP )_) that_WDT are_VBP believed_VBN to_TO be_VB the_DT sites_NNS of_IN cleavage_NN and_CC packaging_NN ._SENT UL15_NP and_CC UL28_NP are_VBP believed_VBN to_TO comprise_VB two_CD subunits_NN of_IN the_DT terminase_NN ._SENT The_DT function_NN of_IN UL33_NP is_VBZ unknown_JJ ,_, but_CC it_PP has_VBZ recently_RB been_VBN reported_VBN to_TO associate_NN with_IN UL28_NP and_CC UL15_NP ._SENT By_IN analogy_NN with_IN phage_NN ,_, the_DT terminase_NN complex_NN would_MD be_VB expected_VBN to_TO bind_VB viral_JJ DNA_NN ,_, transiently_RB associate_NN with_IN the_DT capsids_NNS at_IN a_DT unique_JJ portal_NN vertex_NN ,_, carry_VB out_RP site_NN specific_JJ cleavage_NN of_IN viral_JJ DNA_NN ,_, and_CC translocate_VB the_DT DNA_NN inside_IN the_DT capsids_NNS in_IN an_DT ATP-dependent_JJ fashion_NN ._SENT Several_JJ lines_NNS of_IN evidence_NN support_NN the_DT notion_NN that_IN UL15_NP and_CC UL28_NP make_VBP up_RP two_CD subunits_NN of_IN the_DT terminase_NN ._SENT Protein_NN sequence_NN analysis_NN reveals_VBZ homology_NN between_IN UL15_NP and_CC gp17_JJ (_( a_DT subunit_NN of_IN the_DT T4_NP terminase_NN )_) ,_, including_VBG the_DT Walker_NP A_NP and_CC B_NP boxes_NNS characteristic_JJ of_IN ATP-binding_JJ domains_NNS ._SENT A_DT point_NN mutation_NN in_IN the_DT Walker_NP A_DT box_NN in_IN the_DT HSV-1_NP UL15_NP gene_NN prevents_VBZ cleavage_NN and_CC packaging_NN ,_, suggesting_VBG that_IN ATP_NP hydrolysis_NN is_VBZ required_VBN for_IN the_DT process_NN ._SENT In_IN vitro_NN experiments_NNS indicate_VBP that_IN UL28_NP and_CC its_PP$ homolog_NN in_IN human_JJ cytomegalovirus_NN (_( HCMV_NP )_) bind_NN to_TO a_DT packaging_NN (_( pac_NN )_) site_NN ,_, which_WDT is_VBZ believed_VBN to_TO comprise_VB part_NN of_IN the_DT cleavage_NN recognition_NN sequence_NN ._SENT Furthermore_RB ,_, UL15_NP and_CC UL28_NP transiently_RB associate_VBP with_IN capsid_NN intermediates_NNS and_CC associate_NN with_IN each_DT other_JJ as_RB determined_VBN by_IN coimmunoprecipitation_NN and_CC copurification_NN ._SENT Under_IN certain_JJ experimental_JJ conditions_NNS ,_, UL28_NP requires_VBZ the_DT presence_NN of_IN UL15_NP to_TO be_VB transported_VBN to_TO the_DT nucleus_NN ._SENT Mutations_NNS in_IN UL15_NP and_CC UL28_NP homologues_NNS from_IN HCMV_NP have_VBP been_VBN shown_VBN to_TO promote_VB resistance_NN to_TO the_DT same_JJ antiviral_JJ compounds_NNS ,_, indicating_VBG a_DT possible_JJ interaction_NN between_IN the_DT two_CD proteins_NNS ._SENT Taken_VBN together_RB ,_, these_DT lines_NNS of_IN evidence_NN suggest_VBP UL15_NP and_CC UL28_NP may_MD comprise_VB two_CD subunits_NN of_IN the_DT putative_JJ terminase_NN ._SENT We_PP used_VBD sequence_NN analysis_NN and_CC site-directed_JJ mutagenesis_NN here_RB to_TO provide_VB additional_JJ evidence_NN that_IN UL15_NP is_VBZ part_NN of_IN the_DT terminase_NN complex_NN and_CC to_TO elucidate_VB regions_NNS of_IN UL15_NP that_WDT are_VBP essential_JJ in_IN the_DT cleavage_NN and_CC packaging_NN process_NN ._SENT The_DT homology_NN alignments_NNS reveal_VBP regions_NNS that_WDT are_VBP highly_RB conserved_VBN among_IN UL15_JJ homologues_NNS in_IN the_DT herpesvirus_NN family_NN and_CC bacteriophage_NN terminases_NNS ._SENT It_PP seems_VBZ likely_RB that_IN such_JJ evolutionarily_NNS conserved_VBD regions_NNS will_MD be_VB important_JJ for_IN biological_JJ function_NN ._SENT Mutations_NNS in_IN exon_NN I_PP of_IN the_DT UL15_NP gene_NN were_VBD engineered_VBN in_IN highly_RB conserved_VBN regions_NNS and_CC then_RB analyzed_VBN for_IN biological_JJ activities_NNS exhibited_VBN by_IN the_DT wild-type_JJ UL15_NP protein_NN ,_, including_VBG (_( i_NP )_) the_DT ability_NN to_TO localize_VB to_TO RCs_NP ,_, (_( ii_NP )_) participation_NN in_IN cleavage_NN and_CC packaging_NN ,_, and_CC (_( iii_NNS )_) transient_JJ association_NN with_IN capsid_NN intermediates_NNS ._SENT Cells_NNS and_CC viruses_NNS ._SENT |_SYM African_JJ green_JJ monkey_NN kidney_NN cells_NNS (_( Vero_NP ;_: American_NP Type_NP Culture_NP Collection_NP ,_, Rockville_NP ,_, Md._NP )_) were_VBD propagated_VBN and_CC maintained_VBN as_IN described_VBN previously_RB ._SENT MV_NP cells_NNS are_VBP a_DT Vero_NP cell_NN line_NN expressing_VBG a_DT full-length_JJ UL9_NN containing_VBG mutation_NN G354A_NP in_IN motif_NN V._NP MV_NP cells_NNS potentiate_VBP HSV-1_JJ infection_NN and_CC have_VBP been_VBN used_VBN in_IN the_DT present_JJ study_NN to_TO enhance_VB viral_JJ infection_NN (_( B._NP Martincheva_NP et_FW al._FW ,_, unpublished_JJ data_NNS )_) ._SENT C2_JJ cells_NNS ,_, which_WDT express_VBP the_DT UL15_NP gene_NN products_NNS and_CC are_VBP permissive_JJ for_IN UL15_JJ mutants_NNS ,_, were_VBD propagated_VBN as_IN described_VBN previously_RB ._SENT The_DT KOS_NP strain_NN of_IN HSV-1_NP was_VBD used_VBN as_IN the_DT wild-type_NN virus_NN ,_, and_CC UL15-null_NP viruses_NNS ,_, hr81-1_NN and_CC hr81-2_NN ,_, which_WDT contain_VBP the_DT ICP6::lacZ_NP mutagen_NN cassette_NN inserted_VBN in_IN UL15_JJ exon_NN I_PP and_CC exon_NN II_NP ,_, respectively_RB ,_, were_VBD described_VBN previously_RB ._SENT Four_CD point_NN mutations_NNS in_IN UL15_NP were_VBD introduced_VBN into_IN the_DT viral_JJ genome_NN as_RB described_VBD below_RB ._SENT The_DT G263A_NP mutant_NN with_IN a_DT mutation_NN in_IN the_DT Walker_NP A_NP Box_NP of_IN UL15_NP was_VBD previously_RB described_VBN ._SENT An_DT Sf21_NP cell_NN extract_NN containing_VBG the_DT UL15_NP protein_NN expressed_VBD from_IN a_DT recombinant_JJ baculovirus_NN was_VBD a_DT kind_NN gift_NN from_IN Daniel_NP Tenney_NP (_( Bristol-Myers_NP Squibb_NP )_) ._SENT Alignments_NNS ._SENT |_SYM Using_VBG the_DT HSV-1_NP UL15_NP protein_NN sequence_NN ,_, a_DT PSI-BLAST_NN search_NN of_IN the_DT NCBI_NP database_NN was_VBD performed_VBN to_TO identify_VB possible_JJ homologues_NNS ._SENT The_DT eight_CD human_JJ herpes_NN UL15_NN homologues_NNS were_VBD aligned_VBN using_VBG CLUSTALW_NP (_( Blosum_NP algorithm_NN )_) within_IN MacVector_NP ._SENT Using_VBG the_DT lambda_NN family_NN bacteriophage_NN (_( HK97_JJ )_) gp2_NN (_( terminase_NN subunit_NN )_) protein_NN sequence_NN ,_, a_DT PSI-BLAST_NN search_NN of_IN the_DT NCBI_NP database_NN was_VBD performed_VBN to_TO identify_VB homologues_NNS from_IN other_JJ bacteriophage_NN and_CC the_DT herpesvirus_NN family_NN ._SENT Homologues_NNS gp2_JJ (_( HK97_JJ )_) ,_, UL15_NP (_( HSV-1_NP )_) ,_, gp17_JJ (_( kvp40_NN )_) ,_, and_CC gp17_JJ (_( T4_NP )_) and_CC the_DT consensus_NN sequence_NN from_IN the_DT above_JJ alignment_NN were_VBD aligned_VBN using_VBG CLUSTALW_NN (_( identity_NN algorithm_NN )_) within_IN MacVector_NP ._SENT Sequential_JJ PCR_NP mutagenesis_NN ._SENT |_SYM The_DT G263A_NP mutation_NN in_IN plasmid_NP pcDNAUL15C_NP (_( containing_VBG a_DT CMV_NP promoter_NN and_CC the_DT genomic_JJ UL15_NP sequences_NNS ,_, including_VBG exon_NN I_PP ,_, UL16_NP ,_, UL17_JJ ,_, and_CC exon_NN II_NP )_) has_VBZ been_VBN previously_RB reported_VBN ._SENT In_IN the_DT present_JJ study_NN ,_, four_CD new_JJ point_NN mutations_NNS were_VBD introduced_VBN into_IN the_DT UL15_NP gene_NN ._SENT For_IN mutagenesis_NN ,_, pUC119-UL15GE1_JJ plasmid_NN ,_, containing_VBG exon_NN I_PP of_IN UL15_NP ,_, was_VBD used_VBN as_IN the_DT template_NN for_IN two-step_JJ PCR_NP with_IN the_DT oligonucleotides_NNS listed_VBN in_IN Table_NP ._SENT In_IN each_DT case_NN ,_, the_DT primers_NNS were_VBD designed_VBN to_TO introduce_VB a_DT silent_JJ mutation_NN resulting_VBG in_IN the_DT introduction_NN of_IN a_DT new_JJ restriction_NN enzyme_NN site_NN ._SENT The_DT PCR_NP products_NNS were_VBD subcloned_VBN into_IN pUC119-UL15GE1_NN ,_, replacing_VBG the_DT existing_JJ wild-type_NN UL15_NN sequences_NNS ._SENT These_DT mutant_JJ clones_NNS were_VBD confirmed_VBN by_IN sequence_NN analysis_NN and_CC detection_NN of_IN the_DT new_JJ restriction_NN site_NN within_IN the_DT plasmid_NN ._SENT Subsequently_RB ,_, exon_NN I_PP from_IN the_DT pUC119-UL15GE1_JJ mutant_JJ plasmids_NNS was_VBD subcloned_VBN into_IN pcDNA-UL15C_NN ,_, replacing_VBG the_DT wild-type_NN exon_NN I._NN The_DT pcDNA-UL15C_NN mutant_JJ plasmids_NNS were_VBD used_VBN for_IN transient-transfection_NN and_CC transient-complementation_NN assays_NNS ,_, and_CC the_DT pUC119-UL15GE1_JJ plasmids_NNS were_VBD used_VBN for_IN marker_NN transfer_NN ._SENT Transient_JJ transfection_NN and_CC complementation_NN ._SENT |_SYM Vero_NP cells_NNS were_VBD transfected_VBN with_IN 3_CD mug_NN of_IN pcDNA-UL15C_NN plasmids_NNS containing_VBG wild-type_NN or_CC mutant_JJ versions_NNS of_IN the_DT UL15_NP gene_NN by_IN use_NN of_IN Lipofectamine_NP Plus_NP according_VBG to_TO the_DT manufacturer_NN 's_POS protocol_NN (_( Gibco-BRL_NP )_) ._SENT Cells_NNS were_VBD harvested_VBN at_IN 20_CD h_NN posttransfection_NN and_CC subjected_VBN to_TO Western_JJ blot_NN analysis_NN ._SENT Transient-complementation_NN assays_NNS were_VBD performed_VBN as_IN previously_RB described_VBN ._SENT Briefly_RB ,_, Vero_NP cells_NNS were_VBD transfected_VBN with_IN 3_CD mug_NN of_IN pcDNA-UL15C_NN plasmids_NNS containing_VBG wild-type_NN or_CC mutant_JJ UL15_JJ genes_NNS driven_VBN by_IN a_DT CMV_NP promoter_NN and_CC superinfected_JJ at_IN a_DT multiplicity_NN of_IN infection_NN (_( MOI_NP )_) of_IN 3_CD PFU/cell_NP with_IN UL15-null_NP virus_NN (_( hr81-1_JJ or_CC hr81-2_JJ )_) ._SENT Progeny_NN virus_NN were_VBD harvested_VBN and_CC assayed_VBN on_IN the_DT complementing_VBG cell_NN line_NN (_( C2_NP )_) ._SENT The_DT transient-complementation_NN index_NN was_VBD determined_VBN by_IN dividing_VBG the_DT viral_JJ titer_NN resulting_VBG from_IN the_DT mutant_JJ plasmid_NN by_IN the_DT viral_JJ titer_NN resulting_VBG from_IN the_DT empty_JJ plasmid_NN ._SENT Construction_NN of_IN UL15_JJ mutants_NNS by_IN marker_NN transfer_NN ._SENT |_SYM Marker_NP transfer_NN experiments_NNS were_VBD carried_VBN out_RP as_RB described_VBN previously_RB ._SENT Vero_NP cells_NNS were_VBD transfected_VBN with_IN pUC119-UL15GE1_JJ plasmids_NNS and_CC infectious_JJ hr81-1_JJ DNA_NN (_( containing_VBG a_DT lacZ_NN insertion_NN in_IN exon_NN I_PP of_IN the_DT UL15_NP gene_NN )_) ._SENT Plaques_NNS were_VBD stained_VBN with_IN neutral_JJ red_NN in_IN the_DT presence_NN of_IN the_DT chromogenic_JJ substrate_NN X-Gal_NP (_( 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside_NP )_) ;_: white_JJ plaques_NNS were_VBD purified_VBN three_CD times_NNS on_IN C2_JJ cells_NNS before_IN viral_JJ stocks_NNS were_VBD prepared_VBN ._SENT Recovery_NN of_IN the_DT desired_VBN mutant_NN was_VBD verified_VBN by_IN Southern_NP blot_NN analysis_NN to_TO detect_VB the_DT introduction_NN of_IN new_JJ restriction_NN sites_NNS within_IN the_DT viral_JJ genome_NN ._SENT Preparation_NN of_IN cell_NN extracts_VBZ ._SENT |_SYM Vero_NP cells_NNS ,_, infected_VBN with_IN KOS_NP or_CC UL15_NP mutant_JJ viruses_NNS at_IN an_DT MOI_NP of_IN 10_CD PFU/cell_NP ,_, were_VBD harvested_VBN and_CC prepared_VBN for_IN sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN (_( SDS-PAGE_NP )_) analysis_NN as_IN previously_RB described_VBN ,_, except_IN that_WDT samples_NNS were_VBD sonicated_VBN prior_RB to_TO boiling_VBG ._SENT Capsid_NN preparation_NN ._SENT |_SYM Capsid_NP preparation_NN was_VBD essentially_RB as_RB previously_RB described_VBN except_IN that_DT six_CD large_JJ (_( 225-cm2_JJ )_) flasks_NNS of_IN MV_NP cells_NNS were_VBD infected_VBN at_IN an_DT MOI_NP of_IN 5_CD PFU/cell_NN for_IN each_DT virus_NN ._SENT Sucrose_NN gradients_NNS (_( 20_CD to_TO 50_CD %_NN )_) were_VBD prepared_VBN with_IN a_DT Gradient_NP Master_NP (_( Biocomp_NP )_) ._SENT Sucrose_NN gradient_NN fractions_NNS were_VBD collected_VBN with_IN a_DT piston_NN gradient_JJ fractionator_NN (_( Biocomp_NP )_) ._SENT After_IN fraction_NN collection_NN ,_, the_DT samples_NNS were_VBD precipitated_VBN with_IN trichloroacetic_JJ acid_NN ,_, and_CC the_DT pellets_NNS were_VBD washed_VBN with_IN ethanol_NN and_CC then_RB resuspended_JJ in_IN loading_VBG buffer_NN (_( 200_CD mM_NP Tris_NP [_SYM pH_NN 8.8_CD ]_SYM ,_, 1_CD %_NN [_SYM vol/vol_NN ]_SYM 2-mercaptoethanol_JJ ,_, 2_CD %_NN [_SYM wt/vol_NN ]_SYM SDS_NP ,_, 10_CD %_NN [_SYM vol/vol_NN ]_SYM glycerol_NN ,_, 0.001_CD %_NN [_SYM wt/vol_NN ]_SYM bromphenol_NN blue_NN )_) ._SENT The_DT samples_NNS were_VBD boiled_VBN for_IN 5_CD min_NN and_CC stored_VBD at_IN -20C_NN ._SENT Western_JJ blot_NN analysis_NN ._SENT |_SYM Samples_NP (_( 10_CD to_TO 30_CD mul_NN )_) were_VBD subjected_VBN to_TO SDS-PAGE_NP on_IN 10_CD or_CC 12_CD %_NN polyacrylamide_NN gels_NNS and_CC transferred_VBN to_TO enhanced_JJ chemiluminescence_NN (_( ECL_NP )_) membranes_NNS ._SENT To_TO detect_VB UL15_JJ gene_NN products_NNS ,_, alphaAS9_JJ rabbit_NN polyclonal_JJ antibody_NN (_( generously_RB provided_VBN by_IN Daniel_NP Tenney_NP at_IN Bristol-Myers_NP Squibb_NP )_) ,_, was_VBD used_VBN at_IN a_DT 1:2,000_CD dilution_NN in_IN TBST_NP (_( 10_CD mM_NP Tris_NP [_SYM pH_NN 8.0_CD ]_SYM ,_, 150_CD mM_NP NaCl_NP ,_, 0.05_CD %_NN Tween_NP )_) overnight_RB at_IN 4C_JJ ._SENT To_TO detect_VB VP5_NP gene_NN products_NNS ,_, alpha-HSV_NP MCP_NP ICP5_NP monoclonal_NN antibody_NN (_( ABI_NP ,_, Columbia_NP ,_, Md._NP )_) was_VBD used_VBN at_IN a_DT dilution_NN of_IN 1:2,000_CD in_IN TBST_NP overnight_JJ at_IN 4C_JJ ._SENT Membranes_NNS were_VBD developed_VBN either_RB by_IN ECL_NP (_( Amersham_NP )_) or_CC by_IN using_VBG alkaline_JJ phosphatase_NN (_( AP_NP ;_: Promega_NP or_CC Bio-Rad_NP )_) as_IN instructed_VBN by_IN the_DT manufacturer_NN ._SENT DNA_NP isolation_NN and_CC Southern_JJ blot_NN hybridization_NN ._SENT |_SYM Vero_NP cells_NNS (_( 1.5_CD x_SYM 106_CD )_) were_VBD infected_VBN at_IN an_DT MOI_NP of_IN 10_CD PFU/cell_NN for_IN 18_CD h_NN and_CC harvested_VBN ,_, and_CC the_DT total_JJ DNA_NN was_VBD isolated_VBN ,_, as_RB described_VBN previously_RB ._SENT DNA_NP was_VBD then_RB digested_VBN with_IN BamHI_NP and_CC subjected_VBN to_TO electrophoresis_NN and_CC Southern_JJ blot_NN analysis_NN ._SENT Membranes_NNS were_VBD probed_VBN with_IN a_DT 32P-labeled_JJ BamHI_NP SQ_NP junction_NN fragment_NN ._SENT Immunofluorescence_NN and_CC imaging_NN ._SENT |_SYM Immunofluorescence_NN was_VBD carried_VBN out_RP as_IN described_VBN by_IN Burkham_NP et_FW al._FW ,_, except_IN as_RB noted_VBN ._SENT Cells_NNS were_VBD fixed_VBN in_IN 1.5_CD %_NN formaldehyde_NN in_IN phosphate-buffered_JJ saline_NN (_( PBS_NP )_) for_IN 15_CD min_NN and_CC permeabilized_VBN in_IN cold_JJ acetone_NN at_IN -20C_NN for_IN 2_CD min_NN ._SENT The_DT primary_JJ antibodies_NNS were_VBD applied_VBN for_IN 3_CD h_NN ;_: 39S_JJ ,_, a_DT monoclonal_NN antibody_NN (_( ICP8_NP )_) ,_, was_VBD used_VBN in_IN 3_CD %_NN normal_JJ goat_NN serum_NN (_( NGS_NP )_) in_IN PBS_NP (_( 1:200_CD )_) to_TO detect_VB RCs_NP ,_, and_CC alphaAS9_NN ,_, a_DT polyclonal_JJ antibody_NN in_IN 3_CD %_NN NGS_NP in_IN PBS_NP (_( 1:150_CD )_) ,_, was_VBD used_VBN to_TO detect_VB UL15_NP ._SENT Secondary_JJ antibodies_NNS ,_, i.e._FW ,_, fluorescein_NN isothiocyanate-conjugated_JJ goat_NN anti-mouse_NN and_CC Texas_NP red-conjugated_JJ goat_NN anti-rabbit_NN in_IN 3_CD %_NN NGS_NP in_IN PBS_NP (_( 1:200_CD )_) ,_, were_VBD applied_VBN for_IN 1_CD h._JJ Images_NNS were_VBD arranged_VBN and_CC labeled_VBN by_IN using_VBG Adobe_NP Photoshop_NP 5.0_CD and_CC Illustrator_NP 7.0_CD ._SENT UL15_NP is_VBZ highly_RB conserved_VBN among_IN herpesviruses_NNS ._SENT |_SYM As_RB previously_RB reported_VBN ,_, the_DT HSV-1_NP UL15_NP protein_NN sequence_NN is_VBZ highly_RB conserved_VBN within_IN the_DT Herpesviridae_NP family_NN ._SENT To_TO initiate_VB a_DT structure-function_NN analysis_NN of_IN UL15_NP ,_, we_PP identified_VBD potentially_RB important_JJ residues_NNS by_IN extending_VBG the_DT sequence_NN comparison_NN between_IN HSV-1_NP UL15_NP and_CC other_JJ Herpesviridae_NP family_NN members_NNS ._SENT More_JJR than_IN 50_CD UL15_JJ homologues_NNS from_IN human_JJ and_CC animal_JJ herpesviruses_NNS were_VBD identified_VBN ._SENT Figure_NN shows_VBZ an_DT alignment_NN of_IN UL15_JJ homologues_NNS from_IN all_DT eight_CD human_JJ herpes_NN viruses_NNS ._SENT Twenty_CD highly_RB conserved_VBN regions_NNS (_( CRs_NP )_) were_VBD designated_VBN within_IN the_DT HSV-1_NP UL15_NP protein_NN coding_VBG sequence_NN and_CC its_PP$ homologues_NNS ._SENT These_DT regions_NNS were_VBD chosen_VBN on_IN the_DT basis_NN of_IN the_DT following_VBG criteria_NNS :_: a_DT region_NN must_MD either_RB exhibit_VB 70_CD %_NN homology_NN (_( similarity_NN and_CC identity_NN )_) among_IN all_DT eight_CD human_JJ herpesviruses_NNS or_CC it_PP must_MD exhibit_VB 70_CD %_NN homology_NN to_TO a_DT CR_NN of_IN a_DT bacteriophage_NN terminase_NN ._SENT Nineteen_CD CRs_NNS were_VBD identified_VBN that_IN met_VBN the_DT first_JJ criterion_NN (_( CR2_JJ to_TO CR20_NP )_) ._SENT CR1_NP exhibited_VBD 64_CD %_NN homology_NN among_IN the_DT herpesviruses_NNS ,_, but_CC a_DT subregion_NN of_IN CR1_NP revealed_VBD 70_CD %_NN similarity_NN compared_VBN to_TO bacteriophage_NN terminases_NNS (_( see_VB below_IN )_) ._SENT Although_IN it_PP would_MD have_VB been_VBN possible_JJ to_TO combine_VB some_DT of_IN the_DT CRs_NN into_IN larger_JJR regions_NNS ,_, this_DT was_VBD not_RB done_VBN because_IN we_PP wanted_VBD to_TO distinguish_VB between_IN CRs_NNS that_WDT demonstrated_VBD homology_NN to_TO bacteriophage_NN terminases_NNS and_CC those_DT that_WDT did_VBD not_RB ._SENT The_DT high_JJ degree_NN of_IN sequence_NN conservation_NN probably_RB indicates_VBZ important_JJ regions_NNS for_IN biological_JJ function_NN ._SENT Of_IN the_DT 20_CD CRs_NN ,_, the_DT most_RBS highly_RB conserved_VBN are_VBP CR3_NP and_CC CR6_NP containing_VBG the_DT Walker_NP A_NP and_CC B_NP boxes_NNS ,_, respectively_RB ,_, which_WDT are_VBP found_VBN in_IN ATP-binding_JJ proteins_NNS ._SENT CRs_NNS of_IN UL15_NP are_VBP also_RB conserved_VBN in_IN terminases_NNS of_IN bacteriophage_NN ._SENT |_SYM Previous_JJ protein_NN sequence_NN analysis_NN suggested_VBD a_DT relationship_NN between_IN the_DT UL15_NP protein_NN of_IN channel_NN catfish_NN herpes_NN virus_NN and_CC the_DT gp17_JJ protein_NN encoded_VBN by_IN bacteriophage_NN T4_NP ._SENT More_RBR recent_JJ work_NN has_VBZ suggested_VBN homology_NN between_IN HSV-1_NP UL15_NP and_CC terminases_NNS in_IN the_DT T4_NP family_NN ._SENT This_DT homology_NN was_VBD confined_VBN primarily_RB to_TO the_DT Walker_NP A_NP and_CC B_NP boxes_NNS that_WDT make_VBP up_RP the_DT ATP-binding_NP domain_NN ._SENT Although_IN the_DT previous_JJ analysis_NN of_IN amino_NN acid_NN sequence_NN conservation_NN between_IN bacteriophage_NN terminases_NNS has_VBZ not_RB revealed_VBN extensive_JJ homology_NN outside_IN the_DT ATP-binding_NP domain_NN ,_, we_PP have_VBP now_RB extended_VBN this_DT analysis_NN by_IN using_VBG the_DT identity_NN algorithm_NN within_IN the_DT CLUSTALW_JJ program_NN ._SENT The_DT large_JJ subunit_NN of_IN the_DT terminase_NN from_IN several_JJ members_NNS of_IN the_DT lambda_NN and_CC T_NN phage_NN families_NNS ,_, including_VBG gp2_NN (_( HK97_JJ )_) ,_, gp17_JJ (_( T4_NP )_) ,_, and_CC gp17_JJ (_( KVP40_NP )_) ,_, were_VBD aligned_VBN with_IN HSV-1_NP UL15_NP ._SENT In_IN confirmation_NN of_IN previous_JJ results_NNS ,_, the_DT proteins_NNS were_VBD homologous_JJ in_IN the_DT Walker_NP A_NP and_CC B_NP box_NN regions_NNS but_CC ,_, in_IN addition_NN ,_, 10_CD other_JJ regions_NNS of_IN homology_NN were_VBD identified_VBN ._SENT These_DT include_VBP CRs_NP 1_CD ,_, 3_CD ,_, 4_CD ,_, 6_CD ,_, 8_CD ,_, 9_CD ,_, 13_CD ,_, 14_CD ,_, 16_CD ,_, 17_CD ,_, 19_CD ,_, and_CC 20_CD ._SENT This_DT high_JJ degree_NN of_IN homology_NN suggests_VBZ an_DT evolutionary_JJ relationship_NN between_IN phage_NN and_CC herpesvirus_NN terminases_NNS and_CC may_MD help_VB to_TO identify_VB key_JJ residues_NNS within_IN the_DT HSV-1_NP UL15_NP that_WDT are_VBP essential_JJ for_IN terminase_NN function_NN ._SENT Point_NN mutations_NNS in_IN exon_NN I._NN |_SYM In_IN order_NN to_TO determine_VB whether_IN the_DT CRs_NN in_IN UL15_NP play_VBP a_DT role_NN in_IN terminase_NN function_NN ,_, point_NN mutations_NNS were_VBD designed_VBN in_IN the_DT first_JJ four_CD CRs_NNS ,_, three_CD of_IN which_WDT are_VBP also_RB conserved_VBN in_IN bacteriophage_NN ._SENT In_IN the_DT present_JJ study_NN we_PP report_VBP five_CD mutations_NNS :_: one_CD in_IN CR1_NP (_( conserved_VBN in_IN bacteriophage_NN and_CC herpesviruses_NNS )_) ,_, one_CD in_IN CR2_NP (_( conserved_VBN in_IN herpesviruses_NNS only_RB )_) ,_, two_CD in_IN CR3_NP (_( one_CD conserved_VBN in_IN herpesviruses_NNS and_CC one_CD conserved_VBN in_IN bacteriophage_NN )_) ,_, and_CC one_CD in_IN CR4_NP (_( conserved_VBN in_IN bacteriophges_NNS and_CC herpesviruses_NNS )_) ._SENT Our_PP$ intention_NN was_VBD to_TO identify_VB residues_NNS that_WDT are_VBP either_RB intrinsically_RB important_JJ for_IN terminase_NN activity_NN in_IN general_JJ or_CC are_VBP specifically_RB important_JJ for_IN herpesviruses_NNS ._SENT Mutations_NNS were_VBD engineered_VBN into_IN the_DT pcDNA_NN plasmid_NN containing_VBG the_DT genomic_JJ version_NN of_IN the_DT UL15_NP gene_NN driven_VBN from_IN the_DT CMV_NP promoter_NN ._SENT To_TO determine_VB whether_IN the_DT altered_JJ genes_NNS could_MD produce_VB stable_JJ full-length_JJ UL15_NP protein_NN ,_, Vero_NP cells_NNS were_VBD transfected_VBN with_IN mutant_NN and_CC wild-type_NN versions_NNS of_IN the_DT UL15_NP gene_NN in_IN the_DT pcDNA-UL15_JJ plasmid_NN ._SENT At_IN 20_CD h_NN posttransfection_NN ,_, cells_NNS were_VBD harvested_VBN and_CC subjected_VBN to_TO Western_JJ blot_NN analysis_NN ._SENT Figure_NN shows_VBZ that_IN wild-type_NN and_CC mutant_JJ proteins_NNS were_VBD expressed_VBN at_IN similar_JJ levels_NNS ._SENT This_DT indicates_VBZ that_IN all_DT mutant_JJ UL15_NP proteins_NNS were_VBD relatively_RB stable_JJ when_WRB expressed_VBN in_IN the_DT absence_NN of_IN other_JJ viral_JJ proteins_NNS ._SENT Four_CD of_IN the_DT five_CD exon_NN I_CD mutants_NNS exhibited_VBN severe_JJ growth_NN defects_NNS ._SENT |_SYM To_TO determine_VB whether_IN the_DT mutant_JJ UL15_NP genes_NNS could_MD complement_VB the_DT UL15-null_NP viruses_NNS (_( hr81-1_JJ and_CC hr81-2_JJ )_) ,_, transient-complementation_NN assays_NNS were_VBD performed_VBN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Vero_NP cells_NNS were_VBD transfected_VBN with_IN the_DT pcDNA-UL15C_NN plasmids_NNS containing_VBG wild-type_NN or_CC mutant_JJ versions_NNS of_IN the_DT UL15_NP gene_NN and_CC superinfected_JJ with_IN either_DT hr81-1_JJ or_CC hr81-2_JJ ;_: the_DT titers_NNS of_IN the_DT progeny_NN were_VBD determined_VBN for_IN the_DT complementing_VBG cell_NN line_NN ._SENT Only_RB the_DT wild-type_NN and_CC mutant_JJ Q251E_NN proteins_NNS were_VBD able_JJ to_TO efficiently_RB complement_VB both_DT exon_NN I_PP and_CC exon_NN II_NP UL15-null_NP viruses_NNS ._SENT As_IN previously_RB reported_VBN ,_, the_DT G263A_NP mutation_NN was_VBD unable_JJ to_TO complement_VB UL15_JJ null_JJ mutants_NNS (_( 36_CD ;_: data_NNS not_RB shown_VBN )_) ._SENT In_IN addition_NN ,_, the_DT L120N_NP ,_, Q205E_NP ,_, and_CC Y285S_NP mutations_NNS failed_VBD to_TO complement_VB UL15_JJ null_JJ mutants_NNS in_IN this_DT assay_NN ._SENT Three_CD mutants_NNS --_: -Q205E_NNS ,_, G263A_NP ,_, and_CC Y285S_NP --_: -exhibited_JJ complementation_NN indices_NN significantly_RB less_RBR than_IN that_DT of_IN the_DT empty_JJ plasmid_NN (_( 36_CD )_) ._SENT This_DT may_MD indicate_VB that_IN these_DT mutant_JJ proteins_NNS exert_VBP a_DT transdominant_JJ effect_NN ._SENT Further_JJR experiments_NNS will_MD be_VB necessary_JJ to_TO explore_VB this_DT possibility_NN ._SENT To_TO determine_VB the_DT effect_NN of_IN UL15_JJ mutations_NNS in_IN the_DT context_NN of_IN viral_JJ infections_NNS ,_, each_DT UL15_NP mutant_JJ gene_NN was_VBD transferred_VBN into_IN the_DT viral_JJ genome_NN by_IN marker_NN transfer_NN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Progeny_NN viruses_NNS were_VBD plaque_NN purified_VBN three_CD times_NNS and_CC verified_VBN by_IN gain_NN of_IN a_DT restriction_NN site_NN within_IN the_DT UL15_NP gene_NN ,_, and_CC viral_JJ stocks_NNS were_VBD made_VBN ._SENT Only_RB mutant_JJ Q251E_NN virus_NN was_VBD able_JJ to_TO form_VB plaques_NNS on_IN noncomplementing_JJ Vero_NP cells_NNS ._SENT All_DT of_IN the_DT mutants_NNS (_( L120N_NP ,_, Q205E_NP ,_, Q251E_NP ,_, G263A_NP ,_, and_CC Y285S_NP )_) were_VBD able_JJ to_TO form_VB plaques_NNS on_IN the_DT complementing_VBG cell_NN line_NN ,_, C2_NP ,_, indicating_VBG that_IN the_DT growth_NN defects_NNS were_VBD due_JJ to_TO a_DT UL15_NP mutation_NN and_CC not_RB to_TO a_DT second_JJ mutation_NN in_IN another_DT gene_NN ._SENT Mutant_JJ UL15_NP proteins_NNS were_VBD detected_VBN in_IN infected_JJ cell_NN lysates_NNS ._SENT |_SYM To_TO determine_VB whether_IN stable_JJ protein_NN could_MD be_VB produced_VBN in_IN the_DT context_NN of_IN viral_JJ infection_NN ,_, Western_JJ blot_NN analysis_NN of_IN cells_NNS infected_VBN with_IN each_DT mutant_JJ virus_NN was_VBD performed_VBN as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Antibody_NN to_TO VP5_NP was_VBD used_VBN as_IN an_DT internal_JJ control_NN to_TO demonstrate_VB that_DT efficient_JJ infection_NN had_VBD occurred_VBN ._SENT Figure_NN shows_VBZ that_IN all_DT mutant_JJ viruses_NNS (_( lanes_NNS 2_CD to_TO 7_CD )_) produced_VBD wild-type_NN (_( lane_NN 1_CD )_) levels_NNS of_IN capsid_NN protein_NN VP5_NP (_( marked_VBN with_IN an_DT arrowhead_NN )_) ._SENT Figure_NN shows_VBZ that_IN all_DT mutants_NNS except_IN Y285S_NP (_( lane_NN 7_CD )_) produced_VBD wild-type_NN levels_NNS of_IN UL15_NP ._SENT Interestingly_RB ,_, Y285S_NP could_MD produce_VB stable_JJ protein_NN after_IN overexpression_NN by_IN transfection_NN (_( see_VB Fig._NN ,_, lane_NN 6_CD )_) ._SENT The_DT Y285S_NP mutant_JJ protein_NN could_MD ,_, however_RB ,_, be_VB detected_VBN either_RB in_IN infected_JJ cells_NNS by_IN immunofluorescence_NN or_CC in_IN capsids_NNS by_IN sucrose_NN gradient_JJ centrifugation_NN and_CC Western_JJ blot_NN analysis_NN (_( described_VBN below_IN )_) ._SENT Thus_RB ,_, the_DT Y285S_NP protein_NN is_VBZ made_VBN in_IN transfected_JJ and_CC infected_JJ cells_NNS ;_: however_RB ,_, in_IN the_DT context_NN of_IN infection_NN may_MD be_VB somewhat_RB unstable_JJ ._SENT On_IN the_DT other_JJ hand_NN ,_, the_DT synthesis_NN of_IN wild-type_NN levels_NNS of_IN mutant_JJ proteins_NNS by_IN viruses_NNS L120N_NP ,_, Q205E_NP ,_, Q251E_NP ,_, and_CC G263A_NP indicates_VBZ that_IN no_DT gross_JJ alterations_NNS in_IN protein_NN formation_NN leading_VBG to_TO global_JJ instability_NN have_VBP occurred_VBN (_( Fig._NN ,_, lanes_NNS 2_CD ,_, 3_CD ,_, 4_CD ,_, and_CC 5_CD ,_, respectively_RB )_) ._SENT Cleavage_NN but_CC not_RB DNA_NP synthesis_NN was_VBD inhibited_VBN by_IN UL15_JJ mutants_NNS ._SENT |_SYM Previously_RB ,_, it_PP has_VBZ been_VBN shown_VBN that_IN UL15-null_NP viruses_NNS are_VBP able_JJ to_TO produce_VB viral_JJ DNA_NN but_CC not_RB able_JJ to_TO carry_VB out_RP cleavage_NN and_CC packaging_NN ._SENT To_TO determine_VB whether_IN viruses_NNS bearing_VBG point_NN mutations_NNS were_VBD also_RB impaired_VBN in_IN DNA_NN cleavage_NN ,_, Vero_NP cells_NNS (_( 1.5_CD x_SYM 106_CD )_) were_VBD infected_VBN with_IN wild-type_NN and_CC mutant_JJ viruses_NNS at_IN an_DT MOI_NP of_IN 10_CD PFU/cell_NP ._SENT Total_JJ DNA_NN was_VBD isolated_VBN and_CC subjected_VBN to_TO Southern_JJ blot_NN analysis_NN ,_, as_RB described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT The_DT cleavage_NN of_IN the_DT viral_JJ DNA_NN was_VBD detected_VBN by_IN the_DT presence_NN of_IN S_NP and_CC Q_NP fragments_NNS ._SENT All_DT viruses_NNS were_VBD able_JJ to_TO produce_VB viral_JJ DNA_NN as_IN assessed_VBN by_IN the_DT presence_NN of_IN the_DT joint_JJ SQ_NP fragments_NNS ._SENT On_IN the_DT other_JJ hand_NN ,_, however_RB ,_, S_NP and_CC Q_NP fragments_NNS were_VBD only_RB observed_VBN in_IN DNA_NN harvested_VBN from_IN cells_NNS infected_VBN with_IN wild-type_NN and_CC mutant_JJ Q251E_JJ viruses_NNS (_( Fig._NN ,_, lanes_NNS 1_CD and_CC 4_CD )_) ._SENT This_DT indicates_VBZ that_IN genomic_JJ cleavage_NN does_VBZ not_RB occur_VB in_IN cells_NNS infected_VBN with_IN the_DT remaining_VBG mutant_JJ viruses_NNS (_( L120N_NP ,_, Q205E_NP ,_, G263A_NP ,_, Y285S_NP ,_, and_CC hr81-1_JJ )_) (_( Fig._NN ,_, lanes_NNS 2_CD ,_, 3_CD ,_, 5_CD ,_, 6_CD ,_, and_CC 7_CD ,_, respectively_RB )_) ._SENT All_DT UL15_NP mutant_JJ proteins_NNS were_VBD detected_VBN in_IN RCs_NP ._SENT |_SYM We_PP and_CC others_NNS have_VBP shown_VBN that_IN viral_JJ gene_NN expression_NN ,_, DNA_NN replication_NN ,_, and_CC encapsidation_NN occur_VBP in_IN large_JJ globular_JJ domains_NNS in_IN the_DT nucleus_NN called_VBN RCs_NP ._SENT RCs_NNS are_VBP detected_VBN with_IN antibody_NN to_TO the_DT major_JJ single-stranded_JJ DNA-binding_NN protein_NN (_( ICP8_NP )_) ._SENT It_PP was_VBD previously_RB reported_VBN that_IN wild-type_NP UL15_NP localized_VBD to_TO RCs_NP within_IN the_DT nucleus_NN of_IN infected_JJ cells_NNS ._SENT Immunofluorescence_NN was_VBD performed_VBN to_TO determine_VB whether_IN mutant_JJ forms_NNS of_IN UL15_NP behaved_VBD like_IN the_DT wild_JJ type_NN with_IN respect_NN to_TO nuclear_JJ localization_NN ._SENT In_IN cells_NNS infected_VBN with_IN wild-type_NN virus_NN ,_, UL15_NP was_VBD detected_VBN in_IN RCs_NP ,_, confirming_VBG previous_JJ results_NNS (_( Fig._NN ,_, row_NN 1_CD )_) ._SENT In_IN cells_NNS infected_VBN with_IN UL15-null_NP virus_NN (_( hr81-1_JJ )_) ,_, RCs_NP were_VBD present_JJ ,_, as_RB detected_VBN by_IN anti-ICP8_JJ antibody_NN ,_, but_CC UL15_NP was_VBD not_RB detected_VBN (_( Fig._NN ,_, row_NN 2_CD )_) ._SENT In_IN cells_NNS infected_VBN with_IN all_DT mutant_JJ viruses_NNS ,_, UL15_NP was_VBD detected_VBN in_IN RCs_NP ._SENT Cells_NNS infected_VBN with_IN mutant_JJ Q205E_NNS ,_, are_VBP shown_VBN in_IN Fig._NN ,_, row_NN 3_CD ,_, as_IN a_DT representative_JJ example_NN ._SENT Thus_RB ,_, although_IN UL15_JJ protein_NN from_IN cells_NNS infected_VBN with_IN mutant_JJ Y285S_NNS was_VBD undetectable_JJ by_IN Western_JJ blot_NN ,_, UL15_NP was_VBD clearly_RB detectable_JJ by_IN immunofluorescence_NN ,_, although_IN it_PP exhibits_VBZ a_DT somewhat_RB fainter_JJR staining_VBG pattern_NN than_IN that_WDT observed_VBD in_IN cells_NNS infected_VBN with_IN wild-type_NN virus_NN (_( data_NNS not_RB shown_VBN )_) ._SENT This_DT finding_NN suggests_VBZ that_IN all_DT mutant_JJ proteins_NNS are_VBP synthesized_VBN ,_, folded_VBD properly_RB ,_, and_CC correctly_RB transported_VBN to_TO the_DT RCs_NP ,_, but_CC in_IN the_DT case_NN of_IN mutant_JJ Y285S_NP ,_, the_DT UL15_NP proteins_NNS maybe_RB somewhat_RB unstable_JJ ._SENT Transient_JJ capsid_NN association_NN of_IN UL15_NP was_VBD maintained_VBN in_IN all_DT of_IN the_DT UL15_JJ mutant_JJ viruses_NNS ._SENT |_SYM Multiple_NP bands_NNS that_WDT react_VBP with_IN the_DT UL15_NP antibody_NN ,_, alphaAS9_NN ,_, were_VBD previously_RB reported_VBN to_TO associate_VB with_IN capsids_NNS ._SENT The_DT 81-kDa_NP UL15_NP protein_NN was_VBD found_VBN to_TO be_VB associated_VBN more_RBR strongly_RB with_IN B_NP capsids_NNS than_IN with_IN C_NP capsids_NNS ._SENT We_PP wanted_VBD to_TO examine_VB whether_IN the_DT UL15_NP point_NN mutations_NNS would_MD alter_VB the_DT ability_NN of_IN the_DT 81-kDa_JJ UL15_NP protein_NN to_TO bind_VB to_TO capsids_NNS ._SENT Western_JJ blot_NN analysis_NN with_IN alphaAS9_NN (_( UL15_NP )_) was_VBD performed_VBN on_IN capsids_NNS isolated_VBN from_IN MV_NP cells_NNS infected_VBN with_IN mutant_NN or_CC wild-type_NN viruses_NNS ._SENT Capsid_NN bands_NNS were_VBD purified_VBN by_IN sucrose_NN gradient_JJ centrifugation_NN and_CC collected_VBN with_IN a_DT piston_NN gradient_JJ fractionator_NN (_( Biocomp_NP )_) as_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ._SENT Figure_NN shows_VBZ Western_JJ blots_NNS of_IN sucrose_NN gradient_NN fractions_NNS for_IN wild-type_NN (_( KOS_NP )_) and_CC mutant_JJ viruses_NNS ._SENT In_IN the_DT top_JJ panel_NN for_IN each_DT virus_NN ,_, VP5_NP was_VBD detected_VBN ,_, indicating_VBG which_WDT fractions_NNS contained_VBD capsids_NNS ._SENT This_DT was_VBD confirmed_VBN visually_RB as_IN fraction_NN samples_NNS were_VBD collected_VBN (_( data_NNS not_RB shown_VBN )_) ._SENT Mutant_JJ Q251E_NNS was_VBD able_JJ to_TO produce_VB A_DT ,_, B_NP ,_, and_CC C_NP capsids_NNS similar_JJ to_TO wild_JJ type_NN ._SENT All_DT other_JJ mutants_NNS produced_VBD only_JJ B_NP capsids_NNS similar_JJ to_TO the_DT UL15-null_NP virus_NN (_( hr81-1_JJ )_) ._SENT In_IN the_DT bottom_JJ panel_NN for_IN each_DT virus_NN ,_, the_DT 81-kDa_NP UL15_NP protein_NN was_VBD detected_VBN by_IN use_NN of_IN antibody_NN alphaAS9_NN ._SENT The_DT wild-type_NN and_CC Q251E_NP 81-kDa_NP UL15_NP proteins_NNS were_VBD found_VBN to_TO associate_VB more_RBR strongly_RB with_IN B_NP capsids_NNS than_IN C_NP capsids_NNS ._SENT The_DT UL15-null_NP virus_NN ,_, hr81-1_NN ,_, did_VBD not_RB produce_VB UL15_JJ protein_NN ._SENT UL15_JJ protein_NN produced_VBN in_IN cells_NNS infected_VBN with_IN mutant_JJ viruses_NNS L120N_NP ,_, Q205E_NP ,_, G263A_NP ,_, and_CC Y285S_NP was_VBD also_RB found_VBN to_TO associate_NN with_IN B_NP capsids_NNS ._SENT This_DT suggests_VBZ that_IN CRs_NP 1_CD to_TO 4_CD are_VBP not_RB essential_JJ for_IN the_DT association_NN of_IN UL15_JJ protein_NN with_IN B_NP capsids_NNS ._SENT In_IN summary_NN ,_, it_PP appears_VBZ that_IN the_DT failure_NN of_IN mutants_NNS L120N_NP ,_, Q205E_NP ,_, G263A_NP ,_, and_CC Y285S_NP to_TO cleave_VB and_CC package_VB viral_JJ DNA_NN is_VBZ not_RB due_JJ to_TO the_DT inability_NN of_IN UL15_NP to_TO associate_VB with_IN B_NP capsids_NNS ._SENT HSV-1_NP DNA_NP cleavage_NN and_CC packaging_NN is_VBZ a_DT complex_JJ process_NN that_WDT bears_VBZ many_JJ similarities_NNS to_TO the_DT cleavage_NN and_CC packaging_NN process_NN in_IN the_DT better-studied_JJ bacteriophage_NN ._SENT By_IN analogy_NN with_IN bacteriophage_NN ,_, HSV-1_NP appears_VBZ to_TO encode_VB a_DT terminase_NN that_WDT is_VBZ essential_JJ for_IN encapsidation_NN and_CC the_DT production_NN of_IN progeny_NN virus_NN ._SENT HSV-1_NP UL15_NP has_VBZ been_VBN identified_VBN as_IN a_DT putative_JJ component_NN of_IN the_DT terminase_NN ._SENT By_IN using_VBG sequence_NN analysis_NN ,_, we_PP were_VBD able_JJ to_TO identify_VB regions_NNS in_IN the_DT HSV-1_NP UL15_NP protein_NN sequence_NN conserved_VBN among_IN homologues_NNS in_IN the_DT herpesvirus_NN family_NN ._SENT Even_RB more_RBR striking_JJ was_VBD the_DT observation_NN that_IN 12_CD of_IN the_DT 20_CD CRs_NNS were_VBD also_RB found_VBN in_IN HK97_NP ,_, T4_NP ,_, and_CC Kvp40_NP bacteriophage_NN terminases_NNS ._SENT This_DT analysis_NN extended_VBD the_DT original_JJ work_NN of_IN Davison_NP et_FW al._FW and_CC Mitchell_NP et_FW al._FW showing_NN that_IN UL15_NP was_VBD similar_JJ to_TO T4_NP gp17_JJ primarily_RB in_IN the_DT region_NN of_IN the_DT Walker_NP A_NP and_CC B_NP boxes_NNS of_IN the_DT ATP-binding_NP domain_NN ._SENT We_PP propose_VBP that_IN these_DT evolutionarily_RB conserved_VBN regions_NNS may_MD be_VB important_JJ for_IN the_DT biological_JJ functions_NNS of_IN the_DT terminase_NN ._SENT In_IN the_DT present_JJ study_NN ,_, we_PP introduced_VBD point_NN mutations_NNS into_IN the_DT HSV-1_NP UL15_NP coding_VBG gene_NN to_TO determine_VB which_WDT regions_NNS are_VBP important_JJ for_IN function_NN ._SENT By_IN analogy_NN with_IN bacteriophage_NN systems_NNS ,_, if_IN UL15_NP is_VBZ a_DT component_NN of_IN the_DT terminase_NN ,_, we_PP might_MD expect_VB that_IN it_PP takes_VBZ part_NN in_IN several_JJ functions_NNS during_IN encapsidation_NN ,_, including_VBG binding_VBG and_CC transporting_VBG concatemeric_JJ DNA_NN to_TO the_DT capsid_NN ,_, docking_VBG at_IN the_DT unique_JJ portal_NN vertex_NN of_IN the_DT capsid_NN ,_, cleavage_NN and_CC packaging_NN of_IN the_DT viral_JJ DNA_NN ,_, and_CC disassociation_NN from_IN the_DT capsid_NN ._SENT Direct_JJ biochemical_JJ analysis_NN of_IN the_DT putative_JJ terminase_NN subunits_NN ,_, UL15_NP and_CC UL28_NP ,_, has_VBZ been_VBN hampered_VBN by_IN the_DT insolubility_NN of_IN these_DT proteins_NNS expressed_VBN in_IN heterologous_JJ expression_NN systems_NNS ._SENT Expression_NN systems_NNS tested_VBN to_TO date_VB include_VB insect_NN cells_NNS infected_VBN with_IN recombinant_JJ baculoviruses_NNS and_CC bacteria_NNS transformed_VBN with_IN expression_NN vectors_NNS (_( D._NP Tenney_NP ,_, unpublished_JJ data_NNS )_) ._SENT In_IN addition_NN to_TO the_DT alignment_NN data_NNS described_VBD above_RB ,_, the_DT strongest_JJS evidences_NNS to_TO date_VB that_IN UL15_NP and_CC UL28_NP are_VBP components_NNS of_IN the_DT terminase_NN complex_NN are_VBP their_PP$ ability_NN to_TO transiently_RB associate_VB with_IN B_NP capsids_NNS during_IN encapsidation_NN ;_: the_DT requirement_NN of_IN UL6_NP ,_, the_DT portal_NN protein_NN ,_, for_IN the_DT transient_JJ association_NN ;_: and_CC the_DT ability_NN of_IN UL28_NP to_TO bind_VB to_TO pac_JJ sequences_NNS ._SENT It_PP was_VBD anticipated_VBN that_IN the_DT introduction_NN of_IN subtle_JJ mutations_NNS in_IN CRs_NN of_IN UL15_NP may_MD result_VB in_IN mutants_NNS with_IN a_DT partial_JJ phenotype_NN that_WDT would_MD be_VB able_JJ to_TO carry_VB out_RP some_DT but_CC not_RB all_RB of_IN the_DT functions_NNS of_IN the_DT putative_JJ terminase_NN ._SENT For_IN instance_NN ,_, it_PP might_MD be_VB possible_JJ to_TO isolate_VB a_DT mutant_NN that_WDT could_MD cleave_VB at_IN the_DT UL_NP terminus_NN but_CC not_RB the_DT US_NP terminus_NN ._SENT Such_JJ data_NNS would_MD support_VB the_DT assignment_NN of_IN UL15_NP as_IN a_DT component_NN of_IN the_DT terminase_NN ._SENT Several_JJ key_JJ residues_NNS and_CC regions_NNS of_IN UL15_NP were_VBD identified_VBN that_WDT are_VBP essential_JJ for_IN cleavage_NN and_CC packaging_NN ._SENT Mutations_NNS in_IN amino_NN acids_NNS 120_CD (_( CR1_NP )_) ,_, 205_NP (_( CR2_NP )_) ,_, 263_NP (_( CR3_NP )_) ,_, and_CC 285_CD (_( CR4_NP )_) resulted_VBD in_IN the_DT inability_NN to_TO cleave_VB viral_JJ DNA_NN ,_, indicating_VBG that_IN these_DT residues_NNS (_( and_CC possibly_RB the_DT CRs_NN they_PP are_VBP a_DT part_NN of_IN )_) may_MD be_VB important_JJ for_IN this_DT aspect_NN of_IN terminase_NN activity_NN ._SENT On_IN the_DT other_JJ hand_NN ,_, all_DT mutant_JJ UL15_NP proteins_NNS were_VBD able_JJ to_TO localize_VB to_TO RCs_NP and_CC to_TO associate_NN with_IN B_NP capsids_NNS ._SENT Thus_RB ,_, the_DT localization_NN to_TO RCs_NP and_CC association_NN with_IN capsids_NNS are_VBP functions_NNS separable_JJ from_IN the_DT ability_NN to_TO participate_VB in_IN cleavage_NN and_CC packaging_NN ._SENT These_DT point_NN mutations_NNS may_MD affect_VB downstream_JJ activity_NN such_JJ as_IN initiation_NN of_IN packaging_NN ,_, cleavage_NN of_IN the_DT first_JJ termini_NNS ,_, translocation_NN of_IN the_DT DNA_NN into_IN the_DT capsid_NN ,_, and_CC the_DT ATP_NP hydrolysis_NN necessary_JJ for_IN the_DT translocation_NN of_IN the_DT DNA_NN ._SENT The_DT mutant_JJ G263A_NP (_( CR3_NP )_) results_NNS in_IN a_DT change_NN in_IN the_DT invariant_JJ glycine_NN in_IN the_DT Walker_NP A_DT box_NN of_IN the_DT ATP-binding_NP domain_NN of_IN the_DT UL15_NP protein_NN ._SENT This_DT mutant_JJ protein_NN may_MD be_VB defective_JJ in_IN the_DT binding_NN and/or_CC hydrolysis_NN of_IN ATP_NP ._SENT Another_DT mutation_NN in_IN CR3_NP ,_, Q251E_NP ,_, behaves_VBZ like_IN wild-type_NN virus_NN ,_, indicating_VBG that_IN a_DT conservative_JJ change_NN in_IN this_DT CR_NN is_VBZ tolerated_VBN ._SENT It_PP is_VBZ possible_JJ that_IN a_DT less_RBR conservative_JJ change_NN at_IN residue_NN 251_CD would_MD not_RB be_VB tolerated_VBN ._SENT Although_IN highly_RB conserved_VBN among_IN herpesvirus_NN homologues_NNS ,_, amino_NN acid_NN 251_CD was_VBD not_RB conserved_VBN among_IN bacteriophage_NN ._SENT This_DT may_MD indicate_VB that_DT amino_NN acid_NN 251_CD is_VBZ not_RB essential_JJ for_IN terminase_NN function_VBP per_FW se_FW ._SENT Mutant_JJ Y285S_NP (_( CR4_NP )_) is_VBZ defective_JJ in_IN cleavage_NN and_CC packaging_NN ._SENT Interestingly_RB ,_, mutant_JJ Y285S_NP protein_NN was_VBD detected_VBN by_IN immunofluorescence_NN and_CC was_VBD found_VBN to_TO be_VB associated_VBN with_IN capsids_NNS but_CC was_VBD not_RB readily_RB visible_JJ on_IN Western_JJ blots_NNS of_IN cells_NNS infected_VBN with_IN mutant_JJ virus_NN ._SENT The_DT mutation_NN at_IN amino_NN acid_JJ 285_CD may_MD cause_VB the_DT mutant_JJ protein_NN to_TO be_VB somewhat_RB unstable_JJ in_IN infected_JJ cell_NN lysate_NNS ;_: however_RB ,_, it_PP may_MD be_VB stabilized_VBN by_IN its_PP$ association_NN with_IN capsids_NNS ._SENT Alternatively_RB ,_, mutant_JJ UL15_NP may_MD be_VB enriched_VBN in_IN the_DT capsid_NN preparation_NN ,_, perhaps_RB by_IN binding_VBG better_JJR than_IN wild-type_NN UL15_NN to_TO capsids_NNS or_CC by_IN binding_VBG irreversibly_RB ._SENT It_PP will_MD be_VB of_IN interest_NN to_TO determine_VB whether_IN this_DT mutant_NN exerts_VBZ a_DT transdominant_JJ effect_NN ._SENT Because_IN of_IN the_DT apparent_JJ instability_NN of_IN the_DT mutant_JJ protein_NN in_IN cell_NN extracts_VBZ ,_, we_PP cannot_MD say_VB whether_IN the_DT defect_NN in_IN cleavage_NN and_CC packaging_NN is_VBZ a_DT result_NN of_IN the_DT specific_JJ mutation_NN in_IN CR4_NP or_CC due_JJ to_TO the_DT relative_JJ instability_NN of_IN the_DT protein_NN ._SENT The_DT presence_NN of_IN the_DT mutant_JJ protein_NN in_IN capsids_NNS ,_, however_RB ,_, may_MD indicate_VB the_DT former_JJ ._SENT Mutants_NNS L120N_NP ,_, Q205E_NP ,_, G263A_NP ,_, and_CC Y285S_NP fail_VBP to_TO cleave_VB and_CC package_VB viral_JJ DNA_NN despite_IN the_DT fact_NN that_IN they_PP can_MD localize_VB and_CC associate_VB with_IN capsids_NNS in_IN a_DT fashion_NN similar_JJ to_TO wild_JJ type_NN ._SENT These_DT results_NNS suggest_VBP that_IN residues_NNS in_IN CRs_NP 1_CD to_TO 4_CD are_VBP involved_VBN in_IN the_DT DNA_NP cleavage_NN reaction_NN ._SENT In_IN summary_NN ,_, the_DT mutational_JJ analysis_NN described_VBN here_RB has_VBZ resulted_VBN in_IN the_DT identification_NN of_IN three_CD separable_JJ functions_NNS of_IN UL15_NP :_: localization_NN to_TO RCs_NP ,_, association_NN with_IN capsids_NNS ,_, and_CC cleavage_NN of_IN viral_JJ DNA_NN ._SENT The_DT similarity_NN of_IN the_DT cleavage_NN phenotype_NN in_IN mutants_NNS in_IN CRs_NP 1_CD to_TO 4_CD indicates_VBZ that_IN this_DT reaction_NN may_MD be_VB carried_VBN out_RP in_IN a_DT synchronized_VBN fashion_NN involving_VBG multiple_JJ regions_NNS of_IN the_DT protein_NN ._SENT UL15_JJ homology_NN alignments_NNS :_: UL15_NP is_VBZ highly_RB conserved_VBN among_IN the_DT herpesvirus_NN family_NN ._SENT UL15_JJ homology_NN alignments_NNS :_: UL15_NP is_VBZ highly_RB conserved_VBN among_IN the_DT herpesvirus_NN family_NN ._SENT A_DT PSI-BLAST_NP search_NN was_VBD performed_VBN on_IN the_DT HSV-1_NP UL15_NP protein_NN sequence_NN to_TO obtain_VB all_PDT its_PP$ homologues_NNS ._SENT The_DT eight_CD human_JJ herpesvirus_NN homologues_NNS were_VBD aligned_VBN using_VBG CLUSTALW_NP (_( Blosum_NP algorithm_NN )_) within_IN MacVector_NP ._SENT We_PP assigned_VBD 20_CD CRs_NN between_IN UL15_NP and_CC its_PP$ homologues_NNS based_VBN on_IN the_DT fact_NN that_IN many_JJ but_CC not_RB all_RB of_IN these_DT regions_NNS are_VBP also_RB conserved_VBN in_IN bacteriophage_NN terminase_NN proteins_NNS (_( see_VB Fig._NN )_) ._SENT The_DT Walker_NP A_NP and_CC B_NP boxes_NNS of_IN the_DT putative_JJ ATP-binding_NP domain_NN are_VBP indicated_VBN ._SENT UL15_NN and_CC phage_NN alignments_NNS ._SENT UL15_NN and_CC phage_NN alignments_NNS ._SENT A_DT PSI-BLAST_NP search_NN was_VBD performed_VBN on_IN gp2_NN from_IN HK97_JJ ._SENT UL15_NP (_( HSV-1_NP )_) ,_, the_DT UL15_NP consensus_NN sequence_NN from_IN Fig._NN [_SYM UL15(con)_NP ]_SYM ,_, gp2_JJ (_( HK97_JJ )_) ,_, gp17v_NP (_( KVP40_NP )_) ,_, and_CC gp17_JJ (_( T4_NP )_) were_VBD aligned_VBN by_IN using_VBG CLUSTALW_NN (_( identity_NN algorithm_NN )_) within_IN MacVector_NP ._SENT Of_IN the_DT 20_CD CRs_NNS shown_VBN in_IN Fig._NN ,_, 12_CD are_VBP also_RB conserved_VBN between_IN HSV_NP and_CC the_DT phage_NN terminases_NNS ._SENT The_DT numbers_NNS above_IN each_DT CR_NN correspond_VB to_TO the_DT CRs_NN shown_VBN in_IN Fig._NN ._SENT UL15_NP detected_VBD by_IN Western_JJ blot_NN analysis_NN ._SENT UL15_NP detected_VBD by_IN Western_JJ blot_NN analysis_NN ._SENT (_( A_NP )_) Western_JJ blot_NN analysis_NN of_IN transiently_RB transfected_JJ cells_NNS ._SENT Vero_NP cells_NNS (_( 2.1_CD x_SYM 106_CD )_) transfected_JJ with_IN a_DT pcDNA_NN plasmid_NN containing_VBG a_DT wild-type_NN or_CC mutant_JJ version_NN of_IN the_DT UL15_NP gene_NN were_VBD harvested_VBN 20_CD h_NN posttransfection_NN ,_, subjected_VBN to_TO SDS-PAGE_NP on_IN a_DT 12_CD %_NN gel_NN ,_, and_CC transferred_VBD to_TO an_DT ECL_NN membrane_NN ._SENT Western_JJ blot_NN analysis_NN was_VBD performed_VBN by_IN using_VBG alphaUL15_NN (_( 1:2,000_CD )_) and_CC AP_NP Immunestar_NP development_NN (_( Bio-Rad_NP )_) ._SENT The_DT arrowhead_NN indicates_VBZ the_DT band_NN corresponding_JJ to_TO the_DT 81-kDa_JJ UL15_NP protein_NN (_( lane_NN 1_CD )_) ._SENT (_( B_NP and_CC C_NP )_) Western_JJ blot_NN analysis_NN of_IN infected_JJ cell_NN lysates_NNS ._SENT Vero_NP cells_NNS (_( 2.1_CD x_SYM 106_CD )_) were_VBD infected_VBN with_IN wild-type_NN or_CC mutant_JJ virus_NN at_IN an_DT MOI_NP of_IN 10_CD PFU/cell_NP and_CC harvested_VBN 20_CD h_NN postinfection_NN ._SENT The_DT samples_NNS were_VBD subjected_VBN to_TO SDS-PAGE_NP on_IN a_DT 12_CD %_NN gel_NN and_CC then_RB transferred_VBN to_TO an_DT ECL_NN membrane_NN ._SENT Western_JJ blot_NN analysis_NN was_VBD performed_VBN by_IN using_VBG alphaVP5_NN (_( 1:2,000_CD )_) and_CC ECL_NP development_NN (_( Amersham_NP Pharmacia_NP )_) (_( B_NP )_) and_CC alphaUL15_JJ (_( 1:2,000_CD )_) and_CC AP_NP development_NN (_( Promega_NP )_) (_( C_NP )_) ._SENT In_IN panel_NN B_NP ,_, the_DT arrowhead_NN indicates_VBZ the_DT position_NN of_IN VP5_NP ._SENT In_IN panel_NN C_NP ,_, the_DT arrowhead_NN indicates_VBZ the_DT position_NN of_IN the_DT 81-kDa_JJ form_NN of_IN UL15_NP ._SENT An_DT extract_NN from_IN insect_NN cells_NNS infected_VBN with_IN a_DT UL15_JJ expressing_VBG baculovirus_NN was_VBD used_VBN as_IN a_DT control_NN for_IN the_DT presence_NN of_IN the_DT 81-kDa_JJ form_NN of_IN UL15_NP (_( lane_NN 9_CD )_) ._SENT The_DT positions_NNS of_IN molecular_JJ mass_JJ markers_NNS (_( in_IN kilodaltons_NNS )_) are_VBP shown_VBN in_IN lane_JJ 1_CD ._SENT Southern_JJ blot_NN analysis_NN of_IN viral_JJ DNA_NN from_IN cells_NNS infected_VBN with_IN wild-type_NN and_CC mutant_JJ viruses_NNS ._SENT Southern_JJ blot_NN analysis_NN of_IN viral_JJ DNA_NN from_IN cells_NNS infected_VBN with_IN wild-type_NN and_CC mutant_JJ viruses_NNS ._SENT (_( A_NP )_) The_DT HSV-1_JJ genome_NN consists_VBZ of_IN two_CD unique_JJ regions_NNS ,_, UL_NP and_CC US_NP ,_, which_WDT are_VBP flanked_VBN by_IN repeated_JJ sequence_NN 